Abstract

ABSTRACT Objective: To assess the diagnostic and prognostic value of magnetic resonance imaging (MRI) in Acute Myeloid Leukemia (AML) complicated with central nervous system leukemia (CNSL). Methods: A total of 84 patients with AML and confirmed of CNSL from January 2010 to September 2019 were selected and underwent MRI scan. We retrospectively analyzed their MRI findings, summarized the imaging features of AML central infiltration, and assessed the guiding significance of MRI on diagnosis and prognosis of this disease. Results: A total of 52 patients (61.90%, 52/84) had abnormal MRI findings, of which 31 cases clearly indicated intracranial infiltration of leukemia. Among the 31 patients, the most common site of infiltration is parenchyma (19/31). Most MRI of these patients showed multiple lesions with low T1 signal and high T2 signal, which were more obvious on enhanced scan. Sensitivity of MRI in diagnosing AML central infiltration was 36.90%. Despite of its low sensitivity, it still had superior diagnostic value on some patients with false-negative CSF. The median disease-free survival (DFS) and overall survival (OS) time of patients with MRI clearly indicated central invasion were 4 and 9 months, respectively. But there was no significant difference in survival analysis compared with MRI negative patients (including abnormal but non-invasive). Conclusion: MRI manifestation of central infiltration in AML patients has certain characteristic findings, which is helpful to improve the diagnostic efficiency. Prognosis of MRI positive patients is relatively worse than that of MRI negative patients however there is no siginificant difference.

Highlights

  • Due to the existence of the blood–brain barrier (BBB), many drugs are inaccessible to central nervous system (CNS)

  • 1 case transformed from myelodysplastic syndrome (MDS), 3 cases transformed from chronic myeloid leukemia (CML)

  • In order to solve this problem, we summarized the magnetic resonance imaging (MRI) manifestations of Acute Myeloid Leukemia (AML) complicated with central nervous system leukemia (CNSL), which contributes to the improvement of diagnostic efficiency

Read more

Summary

Introduction

Due to the existence of the blood–brain barrier (BBB), many drugs are inaccessible to central nervous system (CNS). It seems to be a shelter for leukemia cells [1]. It becomes a common site of involvement and recurrence of leukemia [2]. Because of the different sites of infiltration, the clinical manifestations of central nervous system leukemia (CNSL) are various, such as headache, weakness of limbs, facial paralysis, visual loss and so on [3]. How to improve the diagnostic efficiency and prognosis of CNSL is very important

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call